- Posted on 9 Sep 2025
- 1-minute read
This edition features:
- CREST awarded the Health Economics National Technical Service
- AGITG update
- BCT update
- ANZSA update
- SABR Versus Radiofrequency Ablation and Cryoablation for
- Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial
- TOGA update
- ALLG update
- ANZUP update
- Reporting harms more transparently in trials of cancer drugs
- CREST Virtual Workshop
- ANZGOG update
- TROG update
- Other events